[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353859-105":59,"doc-detail-353859-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hnrpdauf1-facilitates-human-ovarian-cancer-progression-through-activating-fli1-and-maintaining-cisplatin-resistance","HnRPD/AUF1 facilitates human ovarian cancer progression through activating FLI1 and maintaining cisplatin resistance","","Ovarian cancer (OC) is a leading cause of gynecologic cancer mortality, making molecular clarification and therapeutic target discovery critical. Using human OC samples, multiple OC cell lines, and xenograft nude mouse models, the study identifies hnRPD as highly expressed in OC tissues and linked to malignant phenotypes. Mechanistically, GPR137 binds hnRPD to enhance hnRPD stability, while hnRPD stabilizes GPR137 via FLI1-driven transcription and stabilizes RAB8A mRNA to activate downstream signaling. Silencing hnRPD sensitizes cisplatin-resistant OC cells to apoptosis by regulating metabolism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hnrpdauf1-facilitates-human-ovarian-cancer-progression-through-activating-fli1-and-maintaining-cisplatin-resistance/353859/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hnrpdauf1-facilitates-human-ovarian-cancer-progression-through-activating-fli1-and-maintaining-cisplatin-resistance/353859.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does hnRPD play in ovarian cancer progression?","Question",{"text":112,"@type":113},"hnRPD is highly expressed in ovarian cancer tissues and promotes malignant behaviors in vitro and in vivo in OC models.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do GPR137 and FLI1 regulate hnRPD in this study?",{"text":117,"@type":113},"GPR137 binds hnRPD to enhance hnRPD protein stability, and hnRPD reciprocally transactivates GPR137 through the transcription factor FLI1.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is hnRPD important for cisplatin resistance?",{"text":121,"@type":113},"hnRPD upregulates RAB8A by interacting with its mRNA and promoting its stability, which activates downstream signaling and supports aggressive cell behaviors; silencing hnRPD induces apoptosis in cisplatin-resistant cells under cisplatin treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353859,1790823081,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Tang et al. Molecular Cancer (2026) 25:69 [https://doi.org/10.1186/s12943-026-02599-5](https://doi.org/10.1186/s12943-026-02599-5)  \nMolecular Cancer  \nRESEARCH Open Access  \nHnRPD/AUF1 facilitates human ovarian cancer progression through activating FLI1 and maintaining cisplatin resistance  \nChao Tang1*†, Chongying Zhu1,2†, Zihao An1†, Bin Cao3†, Qiang Xu1†, Lin Li4, Yiyao Bao1 and Jiayong Li5  \nAbstract  \nOvarian cancer (OC) is the predominant gynecological cancer and is associated with severe morbidity and high mortality worldwide. Therefore, clarifying the molecular mechanisms underlying OC progression and exploring novel therapeutic targets are important. Here, using human OC samples, different OC cell lines, and xenograft nude mouse models in combination with multiple sequencings, we report that hnRPD, an RNA binding protein that modulates RNA stability, is highly expressed in OC tissues, and contributes to OC cell malignancy in human OC cells cultured in vitro and in OC cell-derived xenograft nude mouse models in vivo. Mechanistically, ectopically expressed GPR137 binds to hnRPD and enhances hnRPD protein stability, which reciprocally transactivates GPR137 through the transcription factor FLI1 . On the other hand, elevated hnRPD upregulates RAB8A expression by interacting with RAB8A mRNA and promoting its stability, leading to activation of downstream cell signaling and thereby enhanced OC cell malignant behaviors including cell proliferation, cell invasion, cell migration, and colony formation ability as well as OC xenograft growth in nude mice. Moreover, cisplatin in combination with silencing of hnRPD expression, significantly induces apoptosis in cisplatin-resistant OC cells through regulation of OC cell metabolism. Therefore, our data provide evidence that hnRPD could represent an innovative prognostic indicator for OC and may be an attractive therapeutic target for improving clinical outcomes in OC treatment.  \nKeywords HnRPD, FLI1, Ovarian cancer, Target  \n†Chao Tang, Chongying Zhu, Zihao An, Bin Cao and Qiang Xu contributed equally to this work.  \n*Correspondence:  \nChao Tang  \n[chtang@zju.edu.cn](chtang@zju.edu.cn)  \n1Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents’ Health and Diseases, No. 3333, Binsheng Rd, Hangzhou 310052, China  \n2The Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2 Road,  \nShanghai 200025, China  \n3Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310057, China  \n4Department of Urology, Third Affiliated Hospital, Naval Medical University, Shanghai 201805, China  \n5State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangzhou 510060, China  \nIntroduction  \nAlthough gynecological cancers affect women’s health worldwide, ovarian cancer (OC) is acknowledged as the primary cause of cancer-associated deaths among gynecological malignancies [1–3]. In recent decades, clinical practice has led to improvements in OC treatment. However, current clinical treatments are limited because of the lack of outstanding early-stage clinical outcomes and inadequate screening methods, which often cause OC tobe diagnosed at more advanced stages [4, 5]. Therapies currently applied for patients with OC fail to eliminate the malignancy of OC, and the five-year survival rate (SR) of OC is below 45%[6]. While several factors, such as central adiposity, family history, circulating vitamins,  \n© The Author(s) 2026, modified publication 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercialNoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed mat","cbCaikMobc6oNZFV","https://ap.wps.com/l/cbCaikMobc6oNZFV","pdf",18963704,27,"English","# Abstract\n# Introduction","[{\"question\":\"What role does hnRPD play in ovarian cancer progression?\",\"answer\":\"hnRPD is highly expressed in ovarian cancer tissues and promotes malignant behaviors in vitro and in vivo in OC models.\"},{\"question\":\"How do GPR137 and FLI1 regulate hnRPD in this study?\",\"answer\":\"GPR137 binds hnRPD to enhance hnRPD protein stability, and hnRPD reciprocally transactivates GPR137 through the transcription factor FLI1.\"},{\"question\":\"Why is hnRPD important for cisplatin resistance?\",\"answer\":\"hnRPD upregulates RAB8A by interacting with its mRNA and promoting its stability, which activates downstream signaling and supports aggressive cell behaviors; silencing hnRPD induces apoptosis in cisplatin-resistant cells under cisplatin treatment.\"}]","HnRPD/AUF1 facilitates human ovarian cancer progression through activating FLI1 and maintaining cisplatin resistance | PDF",1790107633,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92e0182225b2cc7fe61d34cfce8fb167.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afeb88adbf180978ac8ba9dfd22431fd.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bc57707f0bc6c58bb4fa1ee2448fc59.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/284e0f6ce310e26ab816a12c9f97e89c.webp",980,1306]